NOTCH2 and Miyoshi myopathy: In addition to being an active component of the MM-EV cargo, Notch2 has been demonstrated to drive expression of heparanase in malignant MM cells—an enzyme involved in regulating exosomal secretion by cleaving membrane-bound heparan sulfates (Maichl et al., 2023).